Abstract
Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA
This study found that anti-pseudomonal (PsA) coverage is overutilized in diabetic foot infection (DFI), even when broad qualifying criteria are applied. The proposed criteria were poor predictors of PsA growth, which was present in a small number of cases. Patients who did grow PsA were somewhat more likely to have severe DFI, history of DFI, and 90-day history of admission or anti-PsA antibiotic use, but many patients without PsA growth also met these criteria.
Document Type
Poster
Publication Date
12-2024
Recommended Citation
Davis, Hannah PharmD; Walters, Michele PharmD, BCPS, AQ-ID; Ferrell, Sarah PharmD, BCPPS; Patel, Jui PharmD, BCPS; and O'Keefe, Tiffany PharmD, BCGP, "Stepping back: evaluating antipseudomonal antibiotic use in diabetic foot infection." (2024). Pharmacy Residency. 38.
https://researchrepository.parkviewhealth.org/pharmresidency/38